| Texas Fertility Center | 71.7 | 3 | 1 |
| Pacific Fertility Center Los Angeles (PFCLA) | 71.7 | 3 | 1 |
| Colorado Center for Reproductive Medicine | 61.0 | 2 | 1 |
| Sher Fertility | 61.0 | 2 | 1 |
| Human Rights Campaign | 60.0 | 4 | 0 |
| Pacific Fertility Center | 51.7 | 3 | 0 |
| American Society for Reproductive Medicine | 45.8 | 1 | 1 |
| Seattle Reproductive Medicine | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New York | 45.8 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 45.8 | 1 | 1 |
| Duke University Health System | 41.0 | 2 | 0 |
| Psychology Today | 41.0 | 2 | 0 |
| Spectrum Health | 41.0 | 2 | 0 |
| St. Louis Magazine | 41.0 | 2 | 0 |
| UCLA Health System | 41.0 | 2 | 0 |
| Fertility Center of San Antonio | 41.0 | 2 | 0 |
| San Diego Fertility Center | 41.0 | 2 | 0 |
| Shady Grove Fertility Center | 41.0 | 2 | 0 |
| Cooper Health System | 41.0 | 2 | 0 |
| Fertility Centers of Illinois | 41.0 | 2 | 0 |
| New Hope Fertility Center | 41.0 | 2 | 0 |
| Zeeland Community Hospital | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| Progyny, Inc. | 41.0 | 2 | 0 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 41.0 | 2 | 0 |
| assisted reproductive technology | 40.0 | 0 | 3 |
| fertility clinic | 40.0 | 0 | 3 |
| Fertility and Sterility | 40.0 | 0 | 3 |
| Fertility clinic, egg donation agency, and sperm bank policies | 40.0 | 0 | 3 |
| Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates | 40.0 | 0 | 3 |
| GYN-FIV a.s. | 40.0 | 0 | 3 |
| sperm bank | 31.7 | 0 | 2 |
| egg donation | 31.7 | 0 | 2 |
| third-party reproduction | 31.7 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 31.7 | 0 | 2 |
| Reproductive Medicine and Biology | 31.7 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 31.7 | 0 | 2 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 31.7 | 0 | 2 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 31.7 | 0 | 2 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 31.7 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 31.7 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 31.7 | 0 | 2 |
| Artificial insemination and use of a sperm bank at the fertility clinic of the C.H.U.L. (Centre hospitalier de l'université Larval) | 31.7 | 0 | 2 |
| Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates | 31.7 | 0 | 2 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 31.7 | 0 | 2 |
| Single-donor and double-donor sperm intrauterine insemination cycles: does double intrauterine insemination increase clinical pregnancy rates? | 31.7 | 0 | 2 |
| The gradient technique improves success rates in intrauterine insemination cycles of unexplained subfertile couples when compared to swim up technique; a prospective randomized study | 31.7 | 0 | 2 |
| Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment? | 31.7 | 0 | 2 |
| Deep intrauterine insemination and embryo transfer in pigs. | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 31.7 | 0 | 2 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Secrecy, disclosure and everything in-between: decisions of parents of children conceived by donor insemination, egg donation and surrogacy | 31.7 | 0 | 2 |
| Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics | 31.7 | 0 | 2 |
| Optimal timing for elective egg freezing | 31.7 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal? | 31.7 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 31.7 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 31.7 | 0 | 2 |
| Life table (survival) analysis to generate cumulative pregnancy rates in assisted reproduction: are we overestimating our success rates? | 31.7 | 0 | 2 |
| ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes | 31.7 | 0 | 2 |
| Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D) | 31.7 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Comparison of the role of cervical and intrauterine insemination techniques on the incidence of multiple pregnancy after artificial insemination with donor sperm | 31.7 | 0 | 2 |
| Effects of cryopreserved semen quality and timed intrauterine insemination on pregnancy rate and gender of offspring in a donor insemination program | 31.7 | 0 | 2 |
| The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program | 31.7 | 0 | 2 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 31.7 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 31.7 | 0 | 2 |
| Oncofertility: a grand collaboration between reproductive medicine and oncology | 31.7 | 0 | 2 |
| Intrauterine insemination catheters for assisted reproduction: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 31.7 | 0 | 2 |
| The Effects of Total Motile Sperm Count on Spontaneous Pregnancy Rate and Pregnancy After IUI Treatment in Couples with Male Factor and Unexplained Infertility | 31.7 | 0 | 2 |
| A Comparison of Success Rates of Embryo Transfer on Weekdays and Weekends | 31.7 | 0 | 2 |
| Use of letrozole in assisted reproduction: a systematic review and meta-analysis. | 31.7 | 0 | 2 |
| Stimulated intrauterine insemination (SIUI) and donor insemination (DI) as first line management for a selected subfertile population: the Manchester experience | 31.7 | 0 | 2 |
| Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction | 31.7 | 0 | 2 |
| Post-thaw Embryo Transfer Cycles as the Future Hope for Boosting IVF Success Rates | 31.7 | 0 | 2 |
| Introduction of sensitive and specific biomarkers can improve infertility treatment success rates | 31.7 | 0 | 2 |
| Assisted reproduction and fertility preservation techniques in cancer patients | 31.7 | 0 | 2 |
| Optimizing natural fertility | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Direct-to-consumer advertising of success rates for medically assisted reproduction: a review of national clinic websites | 31.7 | 0 | 2 |
| Sexual orientation of women does not affect outcome of fertility treatment with donated sperm. | 31.7 | 0 | 2 |
| Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms | 31.7 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 31.7 | 0 | 2 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 31.7 | 0 | 2 |
| Multiple births from fertility treatment in the UK: A Consensus statement | 31.7 | 0 | 2 |
| Elective single-embryo transfer | 31.7 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| The wobbly evidence base of reproductive medicine | 31.7 | 0 | 2 |
| Misconduct in third-party assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Methods employed to overcome difficult embryo transfer during assisted reproduction treatment | 31.7 | 0 | 2 |
| Who are we? A perspective on the reproductive endocrinologist and infertility specialist in the 21st century | 31.7 | 0 | 2 |
| Subclinical hypothyroidism in the infertile female population: a guideline | 31.7 | 0 | 2 |
| Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates | 31.7 | 0 | 2 |
| The effect of peri-implantation administration of uterine relaxing agents in assisted reproduction treatment cycles: a systematic review and meta-analysis | 31.7 | 0 | 2 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 31.7 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 31.7 | 0 | 2 |
| Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey | 31.7 | 0 | 2 |
| Performing the embryo transfer: a guideline | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion | 31.7 | 0 | 2 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 31.7 | 0 | 2 |
| Assisted reproductive medicine in Poland --Fertility and Sterility Special Interest Group of the Polish Gynaecological Society (SPiN PTG) 2012 report | 31.7 | 0 | 2 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 31.7 | 0 | 2 |
| Helping parents to tell their children about the use of donor insemination (DI) and determining their opinions about open-identity sperm donors | 31.7 | 0 | 2 |
| Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. | 31.7 | 0 | 2 |
| Is there an effect of thyroid autoimmunity on the outcomes of assisted reproduction? | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in cancer patients | 31.7 | 0 | 2 |
| Do malignant diseases affect semen quality? Sperm parameters of men with cancers | 31.7 | 0 | 2 |
| Stability of in vitro fertilization-embryo transfer success rates from the 1989, 1990, and 1991 Clinic-Specific Outcome Assessments | 31.7 | 0 | 2 |
| Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles. | 31.7 | 0 | 2 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 31.7 | 0 | 2 |
| Human immunodeficiency virus (HIV) and infertility treatment: a committee opinion | 31.7 | 0 | 2 |
| Relationship between donor sperm parameters and pregnancy outcome after intrauterine insemination: analysis of 2821 cycles in 1355 couples. | 31.7 | 0 | 2 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 31.7 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 31.7 | 0 | 2 |
| Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility | 31.7 | 0 | 2 |
| Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Life after unsuccessful IVF treatment in an assisted reproduction unit: a qualitative analysis of gains through loss among Chinese persons in Hong Kong. | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| Intrauterine insemination using cryopreserved donor sperm, a methods which increases therapeutic success | 31.7 | 0 | 2 |
| The effect of smoking on infertility treatment in women undergoing assisted reproduction cycles | 31.7 | 0 | 2 |
| Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. | 31.7 | 0 | 2 |
| Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime | 31.7 | 0 | 2 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Parental attitudes toward fertility preservation in boys with cancer: context of different risk levels of infertility and success rates of fertility restoration | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 31.7 | 0 | 2 |
| Functioning of families with primary school-age children conceived using anonymous donor sperm. | 31.7 | 0 | 2 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 31.7 | 0 | 2 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 31.7 | 0 | 2 |
| Risk-sharing or refund programs in assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Reproductive medicine and the law: egg donation in Germany, Spain and other European countries | 31.7 | 0 | 2 |
| Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial | 31.7 | 0 | 2 |
| Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment | 31.7 | 0 | 2 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 31.7 | 0 | 2 |
| Public policy aspects of assisted reproduction. Vth World Congress, IVF and embryo transfer | 31.7 | 0 | 2 |
| Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin | 31.7 | 0 | 2 |
| Intrauterine insemination of cultured peripheral blood mononuclear cells prior to embryo transfer improves clinical outcome for patients with repeated implantation failures | 31.7 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 31.7 | 0 | 2 |
| Posthumous assisted reproduction: a survey of attitudes of couples seeking fertility treatment and the degree of agreement between intimate partners | 31.7 | 0 | 2 |
| Viral infections among couples for assisted reproduction in a fertility clinic in Nigeria. | 31.7 | 0 | 2 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 31.7 | 0 | 2 |
| Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility | 31.7 | 0 | 2 |
| Medical egg freezing: the importance of a patient-centered approach to fertility preservation | 31.7 | 0 | 2 |
| Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death | 31.7 | 0 | 2 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 31.7 | 0 | 2 |
| Managing multiple masculinities in donor insemination: doctors configuring infertile men and sperm donors in Taiwan | 31.7 | 0 | 2 |
| Living Kinship Trouble: Danish Sperm Donors’ Narratives of Relatedness | 31.7 | 0 | 2 |
| The Importance of the Periconception Period: Immediate Effects in Cattle Breeding and in Assisted Reproduction Such as Artificial Insemination and Embryo Transfer | 31.7 | 0 | 2 |
| Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion | 31.7 | 0 | 2 |
| The impact of the new Turkish regulation, imposing single embryo transfer after assisted reproduction technology, on neonatal intensive care unit utilization: a single center experience. | 31.7 | 0 | 2 |
| First line fertility treatment strategies regarding IUI and IVF require clinical evidence | 31.7 | 0 | 2 |
| Genes r us? Making sense of genetic and non-genetic relationships following anonymous donor insemination | 31.7 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 31.7 | 0 | 2 |
| A pilot study of gonadotrophin releasing hormone agonist (GnRHa)/superovulation/donor intrauterine insemination (IUI) after unsuccessful artificial insemination with donor sperm (DI). | 31.7 | 0 | 2 |
| Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? | 31.7 | 0 | 2 |
| American Society for Reproductive Medicine Updates Consent Forms for Egg Donation | 31.7 | 0 | 2 |
| Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET | 31.7 | 0 | 2 |
| The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology | 31.7 | 0 | 2 |
| Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure | 31.7 | 0 | 2 |
| Assisted reproduction: should egg and sperm donors be paid? | 31.7 | 0 | 2 |
| Evaluation of compliance and range of fees among American Society for Reproductive Medicine-listed egg donor and surrogacy agencies | 31.7 | 0 | 2 |
| Effectiveness of a Genetics Self-Instructional Module for Nurses Involved in Egg Donor Screening | 31.7 | 0 | 2 |
| Assisted reproduction technique outcomes for fresh versus deferred cryopreserved day-2 embryo transfer: a retrospective matched cohort study | 31.7 | 0 | 2 |
| Ethical issues of egg donation | 31.7 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 31.7 | 0 | 2 |
| The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. | 31.7 | 0 | 2 |
| Controversies in assisted reproduction: oocyte donation. Protocols for egg donation | 31.7 | 0 | 2 |
| Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer | 31.7 | 0 | 2 |
| Intrauterine insemination versus intracervical insemination in donor sperm treatment | 31.7 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 31.7 | 0 | 2 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 31.7 | 0 | 2 |
| Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients | 31.7 | 0 | 2 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 31.7 | 0 | 2 |
| Bioethical dilemmas of assisted reproduction in the opinions of Polish women in infertility treatment: a research report | 31.7 | 0 | 2 |
| Costs of medically assisted reproduction treatment at specialized fertility clinics in the Danish public health care system: results from a 5-year follow-up cohort study | 31.7 | 0 | 2 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 31.7 | 0 | 2 |
| 1995 assisted reproductive technology success rates: national summary and fertility clinic report. | 31.7 | 0 | 2 |
| Multicentre approaches to donor insemination in the French CECOS Federation: nationwide evaluation, donor matching, screening for genetic diseases and consanguinity. Centre d'Etudes et de Conservation des Oeufs et du Sperme humain. | 31.7 | 0 | 2 |
| Use of fetal oocytes in assisted reproduction | 31.7 | 0 | 2 |
| Optimizing natural fertility: a committee opinion | 31.7 | 0 | 2 |
| Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication | 31.7 | 0 | 2 |
| Expectations for success in fertility treatment involving assisted reproduction | 31.7 | 0 | 2 |
| Reproductive medicine in transition: new developments in embryo transfer | 31.7 | 0 | 2 |
| Intrauterine insemination or intracervical insemination with cryopreserved donor sperm in the natural cycle: a cohort study | 31.7 | 0 | 2 |
| Psychosocial aspects of donor insemination. Sperm donors--their motivations and attitudes to artificial insemination | 31.7 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 31.7 | 0 | 2 |
| The use of urine LH detection kits to time intrauterine insemination with donor sperm | 31.7 | 0 | 2 |
| High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction | 31.7 | 0 | 2 |
| Effectiveness of intrauterine insemination in subfertile couples with an isolated cervical factor: a randomized clinical trial | 31.7 | 0 | 2 |
| Becoming a mother by non-anonymous egg donation: secrecy and the relationship between egg recipient, egg donor and egg donation child | 31.7 | 0 | 2 |
| Varicocelectomy improves intrauterine insemination success rates in men with varicocele | 31.7 | 0 | 2 |
| AIDA for reproductive medicine and the fertility clinic | 31.7 | 0 | 2 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 31.7 | 0 | 2 |
| AIUM practice guideline for ultrasonography in reproductive medicine | 31.7 | 0 | 2 |
| Trust women to choose: a response to John a Robertson's 'Egg freezing and Egg banking: empowerment and alienation in assisted reproduction'. | 31.7 | 0 | 2 |
| Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion | 31.7 | 0 | 2 |
| In-vitro fertilization (IVF), embryo transfer (ET) and assisted reproduction in the State of Israel | 31.7 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 31.7 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 31.7 | 0 | 2 |
| Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| Silver-Rusell syndrome caused by epigenetic alteration in a child conceived by intrauterine insemination from donor sperm | 31.7 | 0 | 2 |
| Misconduct in third-party assisted reproduction: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Gender reassignment and assisted reproduction: An ethical analysis. Bristol Centre for Reproductive Medicine Ethics Advisory Committee | 31.7 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction. The Ethics Committee of the American Society for Reproductive Medicine | 31.7 | 0 | 2 |
| Success rates and cost of a live birth following fresh assisted reproduction treatment in women aged 45 years and older, Australia 2002-2004 | 31.7 | 0 | 2 |
| The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow-up study**Presented in part at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Wa | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents | 31.7 | 0 | 2 |
| Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved | 31.7 | 0 | 2 |
| Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women | 31.7 | 0 | 2 |
| Single Human Embryo Transfer in Assisted Reproduction Programs | 31.7 | 0 | 2 |
| Clinical Cohort Study on the Endocrinology and Vaginal Microbiome of the Luteal Phase in Assisted Reproduction | 31.7 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 31.7 | 0 | 2 |
| Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo Transfer | 31.7 | 0 | 2 |
| Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization? | 31.7 | 0 | 2 |
| LANDA Embryo Freezing Technique. | 31.7 | 0 | 2 |
| Does Local Injury of the Endometrium Improve Controlled Ovarian Hyperstimulation (COH) + Intrauterine Insemination (IUI) Outcome? | 31.7 | 0 | 2 |
| Abstracts for 2017 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference | 31.7 | 0 | 2 |
| What advice should we give our patients to preserve their fertility and avoid needing oocyte donation in the future? - A Social Fertility Preservation program | 31.7 | 0 | 2 |
| Safety data for the use of nasal human menopausal gonadotropins: a potential novel approach for fertility treatment | 31.7 | 0 | 2 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 31.7 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Bed Rest or no Bed Rest? | 31.7 | 0 | 2 |
| Egg Freezing Pilot Study | 31.7 | 0 | 2 |
| How Dose Coenzyme Q10 Supplementation During Infertility Treatment Effects Pregnancy Outcome | 31.7 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 31.7 | 0 | 2 |
| The Accuracy of Endometrial Ultrasound to Predict Implantation | 31.7 | 0 | 2 |
| Effect of Intrauterine Navigation Using Intrauterine Insemination Catheter for Mock Embryo Transfer Prior to Day 3 Embryo Transfer on Pregnancy Rate: A Pilot Study | 31.7 | 0 | 2 |
| The relationship between semen parameters in processed and unprocessed semen with intrauterine insemination success rates | 31.7 | 0 | 2 |
| Effect of Cervical Occlusion During Intrauterine Insemination (IUI) | 31.7 | 0 | 2 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | 31.7 | 0 | 2 |
| 0.2 ml vs. 0.5 Inseminated Volume in Donor Intrauterine Insemination Cycles: A Prospective RCT | 31.7 | 0 | 2 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 31.7 | 0 | 2 |
| Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound | 31.7 | 0 | 2 |
| Comparison of bicarbonate and HEPES-buffered media on pregnancy rates after intrauterine insemination with cryopreserved donor sperm | 31.7 | 0 | 2 |
| AIDS: is it an indication for artificial insemination with anonymous donor sperm? | 31.7 | 0 | 2 |
| Direct intraperitoneal or intrauterine insemination and superovulation in infertility treatment: a randomized study | 31.7 | 0 | 2 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 31.7 | 0 | 2 |
| In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings | 31.7 | 0 | 2 |
| Effect of age on intrauterine insemination with frozen donor sperm | 31.7 | 0 | 2 |
| Intrauterine insemination with frozen sperm increases pregnancy rates in donor insemination cycles under gonadotropin stimulation | 31.7 | 0 | 2 |
| Success of intrauterine insemination using cryopreserved donor sperm is related to the age of the woman and the number of preovulatory follicles | 31.7 | 0 | 2 |
| The value of intrauterine insemination in fertility treatment | 31.7 | 0 | 2 |
| Guide to donor insemination and IVF clinics. A patient's guide or a government league table? | 31.7 | 0 | 2 |
| Success rates following intracytoplasmic sperm injection are improved by using ZIFT vs IVF for embryo transfer | 31.7 | 0 | 2 |
| Methodology of human embryo transfer following assisted reproduction | 31.7 | 0 | 2 |
| Artificial intrauterine insemination with cryogenic donor sperm --initial experience with treatment of infertility in a non-government health facility | 31.7 | 0 | 2 |
| Modified hysterosalpingography catheter for embryo transfer and intrauterine insemination | 31.7 | 0 | 2 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 31.7 | 0 | 2 |
| Does intrauterine insemination offer an advantage to cervical cap insemination in a donor insemination program? | 31.7 | 0 | 2 |
| Use of a single intrauterine insemination of defrosted cryopreserved sperm for therapeutic donor insemination | 31.7 | 0 | 2 |
| Intrauterine insemination with frozen donor sperm: a prospective randomized trial comparing three different sperm preparation techniques | 31.7 | 0 | 2 |
| Reproductive medicine and assisted reproduction--present status and perspectives in the Czech Republic | 31.7 | 0 | 2 |
| The use of fixed distance embryo transfer after IVF/ICSI equalizes the success rates among physicians | 31.7 | 0 | 2 |
| Intrauterine insemination with husband's semen as alternative to other assisted reproduction techniques | 31.7 | 0 | 2 |
| A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice opinion. American Society for Reproductive Immunology Antiphospholipid | 31.7 | 0 | 2 |
| The influence of infertility treatment and assisted reproduction techniques on multiple pregnancy rates | 31.7 | 0 | 2 |
| In vitro fertilization cycles converted to intrauterine insemination because of poor follicular response have low success rates | 31.7 | 0 | 2 |
| Embryo transfer: a critical step in assisted reproduction | 31.7 | 0 | 2 |
| Intrauterine insemination-ready versus conventional semen cryopreservation for donor insemination: a comparison of retrospective results and a prospective, randomized trial | 31.7 | 0 | 2 |
| Two-day IUI treatment cycles are more successful than one-day IUI cycles when using frozen-thawed donor sperm | 31.7 | 0 | 2 |
| A 3 year retrospective review of intrauterine insemination, using cryopreserved donor spermatozoa and cycle monitoring by urinary or serum luteinizing hormone measurements | 31.7 | 0 | 2 |
| Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network | 31.7 | 0 | 2 |
| Infertility treatment and informed consent: current practices of reproductive endocrinologists | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 31.7 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 31.7 | 0 | 2 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 31.7 | 0 | 2 |
| [Towards a single embryo transfer: predictive value of uterine and embryological parameters in assisted reproduction outcome] | 31.7 | 0 | 2 |
| Elective single embryo transfer in assisted reproduction | 31.7 | 0 | 2 |
| Health of children born after the infertility treatment with Assisted Reproduction Technology | 31.7 | 0 | 2 |
| Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial | 31.7 | 0 | 2 |
| Removal of cervical mucus prior to embryo transfer improves pregnancy rates in women undergoing assisted reproduction | 31.7 | 0 | 2 |
| Prediction of an ongoing pregnancy after intrauterine insemination | 31.7 | 0 | 2 |
| Blastocyst production and transfer in clinical assisted reproduction | 31.7 | 0 | 2 |
| Shared-risk or refund programs in assisted reproduction | 31.7 | 0 | 2 |
| Embryo splitting for infertility treatment | 31.7 | 0 | 2 |
| Use of semen quality scores to predict pregnancy rates in couples undergoing intrauterine insemination with donor sperm | 31.7 | 0 | 2 |
| Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 31.7 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 31.7 | 0 | 2 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 31.7 | 0 | 2 |
| Elective single embryo transfer versus double embryo transfer in assisted reproduction | 31.7 | 0 | 2 |
| Single embryo transfer in IVF treatment | 31.7 | 0 | 2 |
| Parenthood motives, well-being and disclosure among men from couples ready to start treatment with intrauterine insemination using their own sperm or donor sperm | 31.7 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 31.7 | 0 | 2 |
| Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results | 31.7 | 0 | 2 |
| Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? | 31.7 | 0 | 2 |
| Laparoscopy for intrauterine insemination and embryo recovery in superovulated ewes at a commercial embryo transfer unit | 31.7 | 0 | 2 |
| Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: a committee opinion | 31.7 | 0 | 2 |
| Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? | 31.7 | 0 | 2 |
| Results after assisted reproduction at a public fertility clinic | 31.7 | 0 | 2 |
| Effect of different embryo transfer strategies on the outcome of assisted reproduction | 31.7 | 0 | 2 |
| Uterine contractile activity at Embryo Transfer – as a new pharmacotherapeutic target in assisted reproduction | 31.7 | 0 | 2 |
| AIUM Practice Guideline for the Performance of a Focused Reproductive Endocrinology and Infertility Scan | 31.7 | 0 | 2 |
| Comparison of pregnancy rates in PCOS patients undergoing clomiphene citrate and IUI treatment with different leading follicular sizes | 31.7 | 0 | 2 |
| Psychosocial factors in reproductive medicine | 31.7 | 0 | 2 |
| Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers | 31.7 | 0 | 2 |
| A “four-cycle program” improves the estimate of the cumulative pregnancy rate and increases the number of actual pregnancies in IUI treatment: a cohort study | 31.7 | 0 | 2 |
| Successful pregnancy following assisted reproduction and transmyometrial embryo transfer in a patient with anatomical distortion of the cervical canal | 31.7 | 0 | 2 |
| Clinical and neonatal outcomes of intrauterine insemination with frozen donor sperm | 31.7 | 0 | 2 |
| ASRM standard embryo transfer protocol template: a committee opinion | 31.7 | 0 | 2 |
| Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes | 31.7 | 0 | 2 |
| Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion | 31.7 | 0 | 2 |
| Reporting assisted reproductive technology success rates on Australian and New Zealand fertility clinic websites | 31.7 | 0 | 2 |
| Assisted Reproductive Technology and the Reproductive Endocrinology and Infertility Specialist in the U.S. Military | 31.7 | 0 | 2 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 31.7 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 31.7 | 0 | 2 |
| Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure | 31.7 | 0 | 2 |
| Androgenicity and fertility treatment in women with unexplained infertility | 31.7 | 0 | 2 |
| The effects of intrauterine insemination and single embryo transfer or modified natural cycle in vitro fertilization on offspring's health-Follow-up of a randomized clinical trial | 31.7 | 0 | 2 |
| The effect of female age on the outcome of intrauterine insemination treatment in a public hospital-assisted reproduction technology unit | 31.7 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 31.7 | 0 | 2 |
| A Quality Improvement Initiative: Using Lean Methodology to Improve Efficiency of the Morning Cycle Monitoring at an Ambulatory Academic Fertility Clinic | 31.7 | 0 | 2 |
| Abstracts presented at the 2019 Foundation for Reproductive Medicine Conference on Translational Reproductive Biology and Clinical Reproductive Endocrinology | 31.7 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 31.7 | 0 | 2 |
| [Medically Assisted Reproduction in Natural Cycle: Outcome Evaluation of a Reproductive Medicine Department] | 31.7 | 0 | 2 |
| Corticosteroids Prior to Embryo Transfer in Assisted Reproduction in Women with Crohn's Disease and Ulcerative Colitis - A Nationwide Cohort Study | 31.7 | 0 | 2 |
| The effect of a natural vaginal product based on honey on the success of intrauterine insemination (IUI) in infertility treatment | 31.7 | 0 | 2 |
| Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion | 31.7 | 0 | 2 |
| EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 31.7 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion | 31.7 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation | 31.7 | 0 | 2 |
| The Impact of Traditional Medicine-Based Lifestyle and Diet on Infertility Treatment in Women Undergoing Assisted Reproduction: A Randomized Controlled Trial | 31.7 | 0 | 2 |
| Evaluation of the effect of the elective blastocyst-stage embryo transfer and freezing strategy on the abandonment of frozen embryos under the Taiwan National Assisted Reproduction Act | 31.7 | 0 | 2 |
| Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population | 31.7 | 0 | 2 |
| [Elective single embryo transfer in assisted reproduction] | 31.7 | 0 | 2 |
| Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial | 31.7 | 0 | 2 |
| Changes in the levels of selected metabolites in the culture medium as a possible tool for the embryo selection in assisted reproduction | 31.7 | 0 | 2 |
| Being a child of donor insemination. Donor Conception Network always advises openness | 31.7 | 0 | 2 |
| Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study | 31.7 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 31.7 | 0 | 2 |
| Importance of early and precise ascertainment of mosaic Turner syndrome for fertility preservation and assisted reproduction counseling | 31.7 | 0 | 2 |
| Factors related to infertility in Brazil and their relationship with success rates after assisted reproduction treatment: an integrative review | 31.7 | 0 | 2 |
| Effect of HCG-Triggered Ovulation on Pregnancy Outcomes in Intrauterine Insemination: An Analysis of 5,610 First IUI Natural Cycles With Donor Sperm in China | 31.7 | 0 | 2 |
| IVM Survey Among Reproductive Medicine Specialists | 31.7 | 0 | 2 |
| Ng Soon Chye | 31.7 | 0 | 2 |
| Early Progesterone Change Associated With Pregnancy Outcome After Fresh Embryo Transfer in Assisted Reproduction Technology Cycles With Progesterone Level of >1.5 ng/ml on Human Chorionic Gonadotropin Trigger Day | 31.7 | 0 | 2 |
| Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion | 31.7 | 0 | 2 |
| The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites | 31.7 | 0 | 2 |
| Simulation training for embryo transfer: findings from the American Society for Reproductive Medicine Embryo Transfer Certificate Course | 31.7 | 0 | 2 |
| [Efficiency of sperm donation: An analysis of 440 qualified sperm donors in Chongqing Human Sperm Bank] | 31.7 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 31.7 | 0 | 2 |
| A Federated Blockchain Approach for Fertility Preservation and Assisted Reproduction in Smart Cities | 31.7 | 0 | 2 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 31.7 | 0 | 2 |
| Efficacy and Safety of Fertility Treatments and Fertility Preservation | 31.7 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 31.7 | 0 | 2 |
| A comparative study of attitudes towards donor insemination and egg donation in recipientspotential donors and the public | 31.7 | 0 | 2 |
| Donor insemination through sperm bank in single women, patients, doctors and children: A psychological follow up. | 31.7 | 0 | 2 |
| Adequate dosage of cryopreserved donor sperm for intrauterine insemination: Variation in recovery from commercial samples and associated fecundity. | 31.7 | 0 | 2 |
| Optimizing utilization of emotional support during infertility treatment | 31.7 | 0 | 2 |
| Pregnancy success rates for lesbian couples undergoing intrauterine insemination | 31.7 | 0 | 2 |
| What is the ideal number of vials of donor sperm to purchase for patients undergoing donor sperm intrauterine insemination (DIUI)? | 31.7 | 0 | 2 |
| Does catheter type and/or sonographer impact success rates for embryo transfer? | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men’s hidden roles in women’s fertility preservation | 31.7 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 31.7 | 0 | 2 |
| Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology | 31.7 | 0 | 2 |
| What are the benefits and harms of intrauterine administration of human chorionic gonadotropin (hCG) around the time of embryo transfer for subfertile women undergoing assisted reproduction? | 31.7 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a survey of OB/GYN residents across united states | 31.7 | 0 | 2 |
| Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment | 31.7 | 0 | 2 |
| Introduction of expanded carrier screening by a large sperm bank improves preconceptual care without altering acceptability of sperm donors | 31.7 | 0 | 2 |
| How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction? | 31.7 | 0 | 2 |
| Openness is sperm and egg donor conception: improving support for donors and their families | 31.7 | 0 | 2 |
| Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction | 31.7 | 0 | 2 |
| Fatherlessness, sperm donors and ‘so what?’ parentage: arguing against the immorality of donor conception through ‘world literature’ | 31.7 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 31.7 | 0 | 2 |
| From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain | 31.7 | 0 | 2 |
| Egg Donor & Surrogacy Institute, EDSI | 31.7 | 0 | 2 |
| Q229883 | 25.8 | 1 | 0 |
| Craigslist | 25.8 | 1 | 0 |
| Johns Hopkins School of Medicine | 25.8 | 1 | 0 |
| Johns Hopkins Hospital | 25.8 | 1 | 0 |
| UCLA Ronald Reagan Medical Center | 25.8 | 1 | 0 |
| Single Mothers by Choice | 25.8 | 1 | 0 |
| Brigham and Women's Hospital | 25.8 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 25.8 | 1 | 0 |
| Butterworth Hospital | 25.8 | 1 | 0 |
| Conceive | 25.8 | 1 | 0 |
| Cooper University Hospital | 25.8 | 1 | 0 |
| Highland Hospital | 25.8 | 1 | 0 |
| Howard County General Hospital | 25.8 | 1 | 0 |
| UCLA Jules Stein Eye Institute | 25.8 | 1 | 0 |
| Mayo School of Health Sciences | 25.8 | 1 | 0 |
| NYU Langone Health | 25.8 | 1 | 0 |
| Nicholas H Noyes Memorial Hospital | 25.8 | 1 | 0 |
| Sibley Memorial Hospital | 25.8 | 1 | 0 |
| Q7541087 | 25.8 | 1 | 0 |
| Strong Memorial Hospital | 25.8 | 1 | 0 |
| UCLA Santa Monica Medical Center | 25.8 | 1 | 0 |
| UCSF Medical Center | 25.8 | 1 | 0 |
| University of Rochester Medical Center | 25.8 | 1 | 0 |
| Victor Velculescu | 25.8 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 25.8 | 1 | 0 |
| Suburban Hospital | 25.8 | 1 | 0 |
| Los Angeles FC | 25.8 | 1 | 0 |
| William G. Nelson | 25.8 | 1 | 0 |
| Charles Limb | 25.8 | 1 | 0 |
| Christine E. Dickson | 25.8 | 1 | 0 |
| Mayo Clinic Graduate School of Biomedical Sciences | 25.8 | 1 | 0 |
| London Women's Clinic | 25.8 | 1 | 0 |
| Sidney Kimmel Comprehensive Cancer Center | 25.8 | 1 | 0 |
| Hartmut Land | 25.8 | 1 | 0 |
| Boston IVF | 25.8 | 1 | 0 |
| Reproductive Science Center | 25.8 | 1 | 0 |
| Duke University Medical Center | 25.8 | 1 | 0 |
| Duke Children's Hospital & Health Center | 25.8 | 1 | 0 |
| Mattel Children's Hospital | 25.8 | 1 | 0 |
| Nyack Hospital | 25.8 | 1 | 0 |
| Reproductive Genetics Institute | 25.8 | 1 | 0 |
| Spectrum Health Blodgett Hospital | 25.8 | 1 | 0 |
| Golisano Children's Hospital | 25.8 | 1 | 0 |
| United States Department of Defense | 20.0 | 0 | 1 |
| Systems Biology in Reproductive Medicine | 20.0 | 0 | 1 |
| Robert Edwards | 20.0 | 0 | 1 |
| Jill Scott | 20.0 | 0 | 1 |
| Gigi Fernández | 20.0 | 0 | 1 |
| embryo transfer | 20.0 | 0 | 1 |
| reproductive medicine | 20.0 | 0 | 1 |
| sperm donation | 20.0 | 0 | 1 |
| Creighton Model FertilityCare System | 20.0 | 0 | 1 |
| Vitrification (ovocytes) | 20.0 | 0 | 1 |
| Volunteer Emotional Support Helplines | 20.0 | 0 | 1 |
| Volks | 20.0 | 0 | 1 |
| AirCraft Casualty Emotional Support Services | 20.0 | 0 | 1 |
| Center for Reproductive Medicine | 20.0 | 0 | 1 |
| covert incest | 20.0 | 0 | 1 |
| Donor Sibling Registry | 20.0 | 0 | 1 |
| emotional support animal | 20.0 | 0 | 1 |
| Endocrinology of reproduction | 20.0 | 0 | 1 |
| fertility preservation | 20.0 | 0 | 1 |
| Fertility testing | 20.0 | 0 | 1 |
| fertility tourism | 20.0 | 0 | 1 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 20.0 | 0 | 1 |
| Medicare Part D coverage gap | 20.0 | 0 | 1 |
| Penn State IFC/Panhellenic Dance Marathon | 20.0 | 0 | 1 |
| medical costs | 20.0 | 0 | 1 |
| Repository for Germinal Choice | 20.0 | 0 | 1 |
| Reproductive endocrinology | 20.0 | 0 | 1 |
| reproductive surgery | 20.0 | 0 | 1 |
| Sara McLanahan | 20.0 | 0 | 1 |
| Screening of potential sperm bank donors | 20.0 | 0 | 1 |
| semen collection | 20.0 | 0 | 1 |
| Slovenian fertility treatment referendum, 2001 | 20.0 | 0 | 1 |
| Special Program of Assisted Reproduction | 20.0 | 0 | 1 |
| Category:A-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:B-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:C-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:FA-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:FL-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:GA-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:High-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Low-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Mid-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Reproductive medicine articles by importance | 20.0 | 0 | 1 |
| Category:Reproductive medicine articles by quality | 20.0 | 0 | 1 |
| Category:Reproductive medicine task force | 20.0 | 0 | 1 |
| Category:Reproductive medicine task force articles | 20.0 | 0 | 1 |
| Category:NA-Class reproductive medicine pages | 20.0 | 0 | 1 |
| Category:NA-importance reproductive medicine pages | 20.0 | 0 | 1 |
| Category:Start-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Stub-Class reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Top-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Unassessed reproductive medicine articles | 20.0 | 0 | 1 |
| Category:Unknown-importance reproductive medicine articles | 20.0 | 0 | 1 |
| Category:List-Class reproductive medicine articles | 20.0 | 0 | 1 |
| intrauterine insemination | 20.0 | 0 | 1 |
| Seminars in Reproductive Medicine | 20.0 | 0 | 1 |
| Molecular Human Reproduction | 20.0 | 0 | 1 |
| Journal of Reproductive Medicine | 20.0 | 0 | 1 |
| Obstetrics, Gynaecology and Reproductive Medicine | 20.0 | 0 | 1 |
| Anna Glasier | 20.0 | 0 | 1 |
| Partner-assisted reproduction | 20.0 | 0 | 1 |
| reproductive endocrinology and infertility | 20.0 | 0 | 1 |
| Rest on the Flight into Egypt | 20.0 | 0 | 1 |
| Harbor at Honfleur | 20.0 | 0 | 1 |
| Lil John Roberts | 20.0 | 0 | 1 |
| single mother | 20.0 | 0 | 1 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 20.0 | 0 | 1 |
| Reproductive medicine in northwest Argentina: traditional and institutional systems | 20.0 | 0 | 1 |
| WikiProject Reproductive medicine | 20.0 | 0 | 1 |
| Consensus on infertility treatment related to polycystic ovary syndrome | 20.0 | 0 | 1 |
| Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome | 20.0 | 0 | 1 |
| An historical look at embryo transfer | 20.0 | 0 | 1 |
| Peter C. Klatsky | 20.0 | 0 | 1 |
| Naprotechnology | 20.0 | 0 | 1 |
| Interactions of sperm perinuclear theca with the oocyte: implications for oocyte activation, anti-polyspermy defense, and assisted reproduction | 20.0 | 0 | 1 |
| Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Temperature of embryo culture for assisted reproduction | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Long-acting FSH versus daily FSH for women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Luteal phase support for assisted reproduction cycles | 20.0 | 0 | 1 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 20.0 | 0 | 1 |
| Synchronised approach for intrauterine insemination in subfertile couples | 20.0 | 0 | 1 |
| Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination | 20.0 | 0 | 1 |
| Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction | 20.0 | 0 | 1 |
| Time-lapse systems for embryo incubation and assessment in assisted reproduction | 20.0 | 0 | 1 |
| Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Advanced sperm selection techniques for assisted reproduction | 20.0 | 0 | 1 |
| Vasodilators for women undergoing fertility treatment | 20.0 | 0 | 1 |
| Time-lapse systems for embryo incubation in assisted reproduction | 20.0 | 0 | 1 |
| Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) | 20.0 | 0 | 1 |
| Conservative treatments in gynaecological cancer for fertility preservation | 20.0 | 0 | 1 |
| Fresh versus frozen embryo transfers for assisted reproduction | 20.0 | 0 | 1 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 20.0 | 0 | 1 |
| Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction | 20.0 | 0 | 1 |
| Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Advanced sperm selection techniques for assisted reproduction | 20.0 | 0 | 1 |
| Heparin for assisted reproduction | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction | 20.0 | 0 | 1 |
| Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles | 20.0 | 0 | 1 |
| Androgens (dehydroepiandrosterone or testosterone) in women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Pain relief for women undergoing oocyte retrieval for assisted reproduction | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Vasodilators for women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction | 20.0 | 0 | 1 |
| Long-acting FSH versus daily FSH for women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility | 20.0 | 0 | 1 |
| Long-acting FSH versus daily FSH for women undergoing assisted reproduction | 20.0 | 0 | 1 |
| Immune therapies for women with history of failed implantation undergoing IVF treatment | 20.0 | 0 | 1 |
| Luteal phase support for assisted reproduction cycles | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction | 20.0 | 0 | 1 |
| Heparin for assisted reproduction | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 20.0 | 0 | 1 |
| Synchronised approach for intrauterine insemination in subfertile couples | 20.0 | 0 | 1 |
| Luteal phase support for assisted reproduction cycles | 20.0 | 0 | 1 |
| Soft versus firm catheters for intrauterine insemination | 20.0 | 0 | 1 |
| Conservative treatments in gynaecological cancer for fertility preservation | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 20.0 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Luteal phase support in assisted reproduction cycles | 20.0 | 0 | 1 |
| Cycle regimens for frozen-thawed embryo transfer | 20.0 | 0 | 1 |
| Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) | 20.0 | 0 | 1 |
| Cervical insemination versus intra-uterine insemination of donor sperm for subfertility | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Semen preparation techniques for intrauterine insemination | 20.0 | 0 | 1 |
| Timing modalities for intrauterine insemination in subfertile couples | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI) | 20.0 | 0 | 1 |
| Soft versus firm catheters for intrauterine insemination | 20.0 | 0 | 1 |
| In vitro maturation in sub fertile patients with polycystic ovarian syndrome undergoing assisted reproduction | 20.0 | 0 | 1 |
| Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles | 20.0 | 0 | 1 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 20.0 | 0 | 1 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception | 20.0 | 0 | 1 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Intrauterine insemination versus fallopian tube sperm perfusion for non tubal infertility | 20.0 | 0 | 1 |
| Luteal phase support in assisted reproduction cycles | 20.0 | 0 | 1 |
| Semen preparation techniques for intrauterine insemination | 20.0 | 0 | 1 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples | 20.0 | 0 | 1 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| The permanent vegetative state: practical guidance on diagnosis and management | 20.0 | 0 | 1 |
| In memoriam: Celso-Ramon Garcia, M.D. (1922-2004), reproductive medicine visionary | 20.0 | 0 | 1 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 20.0 | 0 | 1 |
| Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers | 20.0 | 0 | 1 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 20.0 | 0 | 1 |
| Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment | 20.0 | 0 | 1 |
| Relationship of total motile sperm count and percentage motile sperm to successful pregnancy rates following intrauterine insemination | 20.0 | 0 | 1 |
| Disclosing the identity of sperm donors | 20.0 | 0 | 1 |
| Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial | 20.0 | 0 | 1 |
| Infertility, infertility treatment, and congenital malformations: Danish national birth cohort | 20.0 | 0 | 1 |
| Beckwith-Wiedemann syndrome and assisted reproduction technology (ART) | 20.0 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 20.0 | 0 | 1 |
| Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis | 20.0 | 0 | 1 |
| Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination | 20.0 | 0 | 1 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 20.0 | 0 | 1 |
| Genomic imprinting and assisted reproduction | 20.0 | 0 | 1 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 20.0 | 0 | 1 |
| Article processing charges, funding, and open access publishing at Journal of Experimental & Clinical Assisted Reproduction | 20.0 | 0 | 1 |
| The stork and the syringe: a political history of reproductive medicine | 20.0 | 0 | 1 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 20.0 | 0 | 1 |
| Clarifying the role of three-dimensional transvaginal sonography in reproductive medicine: an evidenced-based appraisal | 20.0 | 0 | 1 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 20.0 | 0 | 1 |
| Category:Medicine/Reproductive medicine task force articles needing expert attention | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination | 20.0 | 0 | 1 |
| Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation | 20.0 | 0 | 1 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 20.0 | 0 | 1 |
| Synergies between assisted reproduction technologies and functional genomics | 20.0 | 0 | 1 |
| Fertility preservation in women with cervical, endometrial or ovarian cancers | 20.0 | 0 | 1 |
| Improving Rice Zinc Biofortification Success Rates Through Genetic and Crop Management Approaches in a Changing Environment | 20.0 | 0 | 1 |
| Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer | 20.0 | 0 | 1 |
| Models Predicting Success of Infertility Treatment: A Systematic Review | 20.0 | 0 | 1 |
| Prognostic factors associated with the success rates of posterior orthodontic miniscrew implants: A subgroup meta-analysis | 20.0 | 0 | 1 |
| Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET) | 20.0 | 0 | 1 |
| Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis | 20.0 | 0 | 1 |
| Targeted genome engineering using designer nucleases: State of the art and practical guidance for application in human pluripotent stem cells | 20.0 | 0 | 1 |
| Bacterial infections in cirrhosis: A critical review and practical guidance | 20.0 | 0 | 1 |
| Fertility treatment in spinal cord injury and other neurologic disease | 20.0 | 0 | 1 |
| Fertility preservation in young patients with cancer | 20.0 | 0 | 1 |
| Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled? | 20.0 | 0 | 1 |
| Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine | 20.0 | 0 | 1 |
| Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women | 20.0 | 0 | 1 |
| Spermatogonial stem cells as a therapeutic alternative for fertility preservation of prepubertal boys | 20.0 | 0 | 1 |
| Fertility preservation for boys and adolescents facing sterilizing medical therapy | 20.0 | 0 | 1 |
| Clinical determinants of mental disorders occurring during the infertility treatment | 20.0 | 0 | 1 |
| Parthenogenesis and Human Assisted Reproduction | 20.0 | 0 | 1 |
| Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens | 20.0 | 0 | 1 |
| Recommendation to Reduce Patients' Blood Pressure and Cholesterol Medication Costs | 20.0 | 0 | 1 |
| Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review | 20.0 | 0 | 1 |
| Bibliometric mapping and clustering analysis of Iranian papers on reproductive medicine in Scopus database (2010-2014) | 20.0 | 0 | 1 |
| Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? | 20.0 | 0 | 1 |
| Selective Regulation of Oocyte Meiotic Events Enhances Progress in Fertility Preservation Methods | 20.0 | 0 | 1 |
| Air quality in the assisted reproduction laboratory: a mini-review | 20.0 | 0 | 1 |
| Stem cells in reproductive medicine: ready for the patient? | 20.0 | 0 | 1 |
| Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? | 20.0 | 0 | 1 |
| Fertility preservation during cancer treatment: clinical guidelines | 20.0 | 0 | 1 |
| The evaluation of pre and post processing semen analysis parameters at the time of intrauterine insemination in couples diagnosed with male factor infertility and pregnancy rates based on stimulation agent. A retrospective cohort study | 20.0 | 0 | 1 |
| The prognostic profile of subfertile couples and treatment outcome after expectant management, intrauterine insemination and in vitro fertilisation: a study protocol for the meta-analysis of individual patient data | 20.0 | 0 | 1 |
| Fertility Sparing Surgery in Gynecologic Cancer | 20.0 | 0 | 1 |
| The presence, role and clinical use of spermatozoal RNAs | 20.0 | 0 | 1 |
| Infertility and reproductive medicine clinics of North America | 20.0 | 0 | 1 |
| Iranian journal of reproductive medicine Yazd Research & Clinical Centre for Infertility | 20.0 | 0 | 1 |
| Clinical and experimental reproductive medicine | 20.0 | 0 | 1 |
| Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation | 20.0 | 0 | 1 |
| Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs | 20.0 | 0 | 1 |
| Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection | 20.0 | 0 | 1 |
| Reproduction and Breast Cancer Risk | 20.0 | 0 | 1 |
| Double versus single homologous intrauterine insemination for male factor infertility: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 20.0 | 0 | 1 |
| Antiretroviral Treatment Sequencing Strategies to Overcome HIV Type 1 Drug Resistance in Adolescents and Adults in Low-Middle-Income Countries | 20.0 | 0 | 1 |
| Strategies for Fertility Preservation in Young Patients with Cancer: A Comprehensive Approach | 20.0 | 0 | 1 |
| Effectiveness of GnRH Antagonist in the Management of Subfertile Couples Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: A Meta-Analysis | 20.0 | 0 | 1 |
| Fertility preservation in young patients′ with cancer | 20.0 | 0 | 1 |
| Gastrointestinal bleeding in patients receiving antiplatelet and anticoagulant therapy: practical guidance for restarting therapy and avoiding recurrences | 20.0 | 0 | 1 |
| Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance | 20.0 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment. Part II-Mental health and development outcomes | 20.0 | 0 | 1 |
| Conjoined human oocytes observed during assisted reproduction: description of three cases and review of the literature | 20.0 | 0 | 1 |
| Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignancies | 20.0 | 0 | 1 |
| Efficacy of luteal phase support with vaginal progesterone in intrauterine insemination: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Therapeutic bronchoscopy for malignant central airway obstruction: success rates and impact on dyspnea and quality of life | 20.0 | 0 | 1 |
| Mary Barton | 20.0 | 0 | 1 |
| PGS-FISH in reproductive medicine and perspective directions for improvement: a systematic review | 20.0 | 0 | 1 |
| Fertility preservation in cancer women: a multidisciplinary approach | 20.0 | 0 | 1 |
| Journal of in vitro fertilization and embryo transfer : IVF | 20.0 | 0 | 1 |
| Seminars in reproductive endocrinology | 20.0 | 0 | 1 |
| Assisted reproduction reviews | 20.0 | 0 | 1 |
| Annual progress in reproductive medicine | 20.0 | 0 | 1 |
| Journal of experimental & clinical assisted reproduction | 20.0 | 0 | 1 |
| International journal of reproductive medicine | 20.0 | 0 | 1 |
| International journal of gynecological obstetrical and reproductive medicine research | 20.0 | 0 | 1 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 20.0 | 0 | 1 |
| JBRA assisted reproduction | 20.0 | 0 | 1 |
| Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis | 20.0 | 0 | 1 |
| Surgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility Preservation | 20.0 | 0 | 1 |
| Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice | 20.0 | 0 | 1 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 20.0 | 0 | 1 |
| Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review | 20.0 | 0 | 1 |
| Are there optimal numbers of oocytes, spermatozoa and embryos in assisted reproduction? | 20.0 | 0 | 1 |
| Should Sabbath Prohibitions Be Overridden to Provide Emotional Support to a Sick Relative? | 20.0 | 0 | 1 |
| Methods for endometrial preparation in frozen-thawed embryo transfer cycles | 20.0 | 0 | 1 |
| Vitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic review | 20.0 | 0 | 1 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 20.0 | 0 | 1 |
| Granulocyte colony-stimulating factor and reproductive medicine: A review | 20.0 | 0 | 1 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 20.0 | 0 | 1 |
| Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine | 20.0 | 0 | 1 |
| Biobanking efforts and new advances in male fertility preservation for rare and endangered species | 20.0 | 0 | 1 |
| Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer | 20.0 | 0 | 1 |
| First do no harm: uterine natural killer (NK) cells in assisted reproduction | 20.0 | 0 | 1 |
| Identifying and Addressing the Needs of Adolescents and Young Adults With Cancer: Summary of an Institute of Medicine Workshop | 20.0 | 0 | 1 |
| Laparoscopic management of ruptured heterotopic pregnancy after intrauterine insemination | 20.0 | 0 | 1 |
| Influence of sexual stimulation on sperm parameters in semen samples collected via masturbation from normozoospermic men or cryptozoospermic men participating in an assisted reproduction programme | 20.0 | 0 | 1 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 20.0 | 0 | 1 |
| Effectivity of heparin in assisted reproduction | 20.0 | 0 | 1 |
| Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple | 20.0 | 0 | 1 |
| Autoimmune factors in assisted reproduction | 20.0 | 0 | 1 |
| Authoritative knowledge and single women's unintentional pregnancies, abortions, adoption, and single motherhood: social stigma and structural violence | 20.0 | 0 | 1 |
| Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK | 20.0 | 0 | 1 |
| Cytoplasmic transfer in assisted reproduction | 20.0 | 0 | 1 |
| Similar success rates with bivalirudin and unfractionated heparin in bare-metal stent implantation | 20.0 | 0 | 1 |
| Is there a benefit of low-dose aspirin in assisted reproduction? | 20.0 | 0 | 1 |
| Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction | 20.0 | 0 | 1 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 20.0 | 0 | 1 |
| John Zhang | 20.0 | 0 | 1 |
| Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate | 20.0 | 0 | 1 |
| Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents | 20.0 | 0 | 1 |
| Birth after the reimplantation of a human embryo | 20.0 | 0 | 1 |
| Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women | 20.0 | 0 | 1 |
| Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients | 20.0 | 0 | 1 |
| Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety | 20.0 | 0 | 1 |
| Transplantation in reproductive medicine: previous experience, present knowledge and future prospects | 20.0 | 0 | 1 |
| Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure | 20.0 | 0 | 1 |
| A short period of ejaculatory abstinence before intrauterine insemination is associated with higher pregnancy rates | 20.0 | 0 | 1 |
| Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment | 20.0 | 0 | 1 |
| Similarin vitromaturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients | 20.0 | 0 | 1 |
| What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? | 20.0 | 0 | 1 |
| Successful treatment of cervical stenosis with hysteroscopic canalization before embryo transfer in patients undergoing IVF: a case series | 20.0 | 0 | 1 |
| A systematic review of sperm donors: demographic characteristics, attitudes, motives and experiences of the process of sperm donation | 20.0 | 0 | 1 |
| Clinical significance of sperm DNA damage in assisted reproduction outcome | 20.0 | 0 | 1 |
| Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? | 20.0 | 0 | 1 |
| Therapeutic cup insemination with cryopreserved donor sperm: prognostic value of cervical mucus score at insemination and the number of motile sperm in mucus at 24 hours | 20.0 | 0 | 1 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 20.0 | 0 | 1 |
| Pregnancy and assisted reproduction techniques in men and women after cancer treatment | 20.0 | 0 | 1 |
| Swedish sperm donors are driven by altruism, but shortage of sperm donors leads to reproductive travelling | 20.0 | 0 | 1 |
| Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature | 20.0 | 0 | 1 |
| Raman microspectroscopy: shining a new light on reproductive medicine | 20.0 | 0 | 1 |
| Q28344605 | 20.0 | 0 | 1 |
| A PTSD symptoms trajectory mediates between exposure levels and emotional support in police responders to 9/11: a growth curve analysis | 20.0 | 0 | 1 |
| Success rates for consent and collection of prenatal biological specimens in an epidemiologic survey of child health | 20.0 | 0 | 1 |
| Increased count, motility, and total motile sperm cells collected across three consecutive ejaculations within 24 h of oocyte retrieval: implications for management of men presenting with low numbers of motile sperm for assisted reproduction | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 20.0 | 0 | 1 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Soy Intake Modifies the Relation Between Urinary Bisphenol A Concentrations and Pregnancy Outcomes Among Women Undergoing Assisted Reproduction | 20.0 | 0 | 1 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception | 20.0 | 0 | 1 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 20.0 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial | 20.0 | 0 | 1 |
| Dietary Folate and Reproductive Success Among Women Undergoing Assisted Reproduction | 20.0 | 0 | 1 |
| Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment | 20.0 | 0 | 1 |
| Paternal Urinary Concentrations of Parabens and Other Phenols in Relation to Reproductive Outcomes among Couples from a Fertility Clinic | 20.0 | 0 | 1 |
| Biomarkers in reproductive medicine: the promise, and can it be fulfilled? | 20.0 | 0 | 1 |
| Ontogeny of adenosine deaminase in the mouse decidua and placenta: immunolocalization and embryo transfer studies | 20.0 | 0 | 1 |
| Effect of sperm DNA fragmentation on clinical outcome of frozen-thawed embryo transfer and on blastocyst formation | 20.0 | 0 | 1 |
| Congenital Malformations among Babies Born Following Letrozole or Clomiphene for Infertility Treatment | 20.0 | 0 | 1 |
| Three Giants in the Cradle of Reproductive Medicine; Reproduction Theories of the Seventeenth Century as Discerned by Pregnancy Portraiture in the Oeuvre of Jan Vermeer | 20.0 | 0 | 1 |
| Practical guidance on informed consent for pediatric participants in a biorepository | 20.0 | 0 | 1 |
| Mammalian fertility preservation through cryobiology: value of classical comparative studies and the need for new preservation options | 20.0 | 0 | 1 |
| The Lone Inventor: Low Success Rates and Common Errors Associated with Pro-Se Patent Applications | 20.0 | 0 | 1 |
| Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials | 20.0 | 0 | 1 |
| Roger Gosden | 20.0 | 0 | 1 |
| Success rates of nuclear short tandem repeat typing from different skeletal elements | 20.0 | 0 | 1 |
| The effect of intrauterine human chorionic gonadotropin injection before embryo transfer on the implantation and pregnancy rate in infertile patients: A randomized clinical trial | 20.0 | 0 | 1 |
| Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome | 20.0 | 0 | 1 |
| The effect of endometrial injury on pregnancy rate in frozen-thawed embryo transfer: A randomized control trial | 20.0 | 0 | 1 |
| Reproductive Endocrinology and Infertility | 20.0 | 0 | 1 |
| GIFT The Hope for Future Infertility Treatment | 20.0 | 0 | 1 |
| Urinary Concentrations of Phthalate Metabolites in Relation to Pregnancy Loss among Women Conceiving with Medically Assisted Reproduction | 20.0 | 0 | 1 |
| Blood donor screening for West Nile virus (WNV) revealed acute Usutu virus (USUV) infection, Germany, September 2016 | 20.0 | 0 | 1 |
| William F. Crowley | 20.0 | 0 | 1 |
| More research, more responsibility: the expansion of duty to warn in cancer patients considering fertility preservation | 20.0 | 0 | 1 |
| Hysteroscopic polypectomy prior to infertility treatment: A cost analysis and systematic review | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 20.0 | 0 | 1 |
| Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 20.0 | 0 | 1 |
| Fertility preservation in women with borderline ovarian tumours. | 20.0 | 0 | 1 |
| Where are oncofertility and fertility preservation treatments heading in 2016? | 20.0 | 0 | 1 |
| Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer | 20.0 | 0 | 1 |
| Pregnancy after oocyte donation in 45, X Turner syndrome women, complicated by gestational diabetes and polyhydramnios. Case report and mini-review of literature | 20.0 | 0 | 1 |
| Midwest Fertility Specialists | 20.0 | 0 | 1 |
| Howard and Georgeanna Jones Foundation for Reproductive Medicine | 20.0 | 0 | 1 |
| How teacher emotional support motivates students: The mediating roles of perceived peer relatedness, autonomy support, and competence | 20.0 | 0 | 1 |
| Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction | 20.0 | 0 | 1 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Fertility Preservation after a Cancer Diagnosis: A Systematic Review of Adolescents', Parents', and Providers' Perspectives, Experiences, and Preferences | 20.0 | 0 | 1 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 20.0 | 0 | 1 |
| Institute for Reproductive Medicine | 20.0 | 0 | 1 |
| Reproductive Medicine Institute | 20.0 | 0 | 1 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 20.0 | 0 | 1 |
| Clinical, emotional support vital to success of AIDS unit | 20.0 | 0 | 1 |
| A public philosophy of assisted reproduction for New York State | 20.0 | 0 | 1 |
| Alternative treatments in reproductive medicine. The vexing problem of 'seemingly impeccable trials...'. | 20.0 | 0 | 1 |
| Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes | 20.0 | 0 | 1 |
| Recruitment strategies in two reproductive medicine network infertility trials | 20.0 | 0 | 1 |
| Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Infertile couples' experience of family stress while women are hospitalized for ovarian hyperstimulation syndrome during infertility treatment | 20.0 | 0 | 1 |
| ‘An ounce of prevention is worth a pound of cure’: the case for and against GnRH-agonist for fertility preservation | 20.0 | 0 | 1 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 20.0 | 0 | 1 |
| Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype. | 20.0 | 0 | 1 |
| Distributive justice and infertility treatment in Canada | 20.0 | 0 | 1 |
| Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations | 20.0 | 0 | 1 |
| The impact of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) on short term diabetic medication costs | 20.0 | 0 | 1 |
| Six-month healing success rates after endodontic treatment using the novel GentleWave™ System: The pure prospective multi-center clinical study | 20.0 | 0 | 1 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 20.0 | 0 | 1 |
| Prevention of prematurity by single embryo transfer | 20.0 | 0 | 1 |
| Letrozole versus clomiphene for infertility in the polycystic ovary syndrome | 20.0 | 0 | 1 |
| Regulating (or not) reproductive medicine: an alternative to letting the market decide | 20.0 | 0 | 1 |
| Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors | 20.0 | 0 | 1 |
| Patient Education and Emotional Support Practices in Abortion Care Facilities in the United States | 20.0 | 0 | 1 |
| Body mass index and intercourse compliance | 20.0 | 0 | 1 |
| Altering hirsutism through ovulation induction in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| A philosopher looks at assisted reproduction | 20.0 | 0 | 1 |
| Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Inhibin, activin, and follistatin in reproductive medicine | 20.0 | 0 | 1 |
| Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism | 20.0 | 0 | 1 |
| Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial | 20.0 | 0 | 1 |
| Predictors of pregnancy in women with polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Can instructional and emotional support in the first-grade classroom make a difference for children at risk of school failure? | 20.0 | 0 | 1 |
| Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial | 20.0 | 0 | 1 |
| Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. | 20.0 | 0 | 1 |
| Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene | 20.0 | 0 | 1 |
| Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome | 20.0 | 0 | 1 |
| Psychosocial Adjustment among Children Conceived via Donor Insemination by Lesbian and Heterosexual Mothers | 20.0 | 0 | 1 |
| Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol | 20.0 | 0 | 1 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 20.0 | 0 | 1 |
| In vitro fertilization - analysis of data in Czech National Assisted Reproduction Register from years 2007-2011 | 20.0 | 0 | 1 |
| Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer | 20.0 | 0 | 1 |
| Comparison of fertility data from vaginal vs intrauterine insemination of frozen-thawed dog semen: a retrospective study. | 20.0 | 0 | 1 |
| The collection of data on assisted reproduction treatments in the UK: Recommendations by BFS and ACE | 20.0 | 0 | 1 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 20.0 | 0 | 1 |
| Cultivation of the notochord of a Balanoglossus species in diffusion chambers | 20.0 | 0 | 1 |
| Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set | 20.0 | 0 | 1 |
| Medical genetics in reproductive medicine | 20.0 | 0 | 1 |
| Laser-assisted hatching in assisted reproduction. | 20.0 | 0 | 1 |
| Establishment of the data base of large human sperm bank and its application | 20.0 | 0 | 1 |
| It ‘did what it said on the tin’ – Participant's views of the content and process of donor conception parenthood preparation workshops | 20.0 | 0 | 1 |
| Safety issues in assisted reproduction technology. From theory to reality--just what are the data telling us about ICSI offspring health and future fertility and should we be concerned? | 20.0 | 0 | 1 |
| Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. | 20.0 | 0 | 1 |
| Intrauterine insemination versus timed intercourse for cervical hostility in subfertile couples | 20.0 | 0 | 1 |
| Transvaginal ovarian trauma, poor responders and improvement of success rates in IVF: anecdotal data and a hypothesis | 20.0 | 0 | 1 |
| The merits of blastocyst versus cleavage stage embryo transfer: a Cochrane review | 20.0 | 0 | 1 |
| Proteomics of human spermatozoa, protamine content and assisted reproduction outcome. | 20.0 | 0 | 1 |
| Keeping the Spirits Up: The Effect of Teachers' and Parents' Emotional Support on Children's Working Memory Performance. | 20.0 | 0 | 1 |
| Assisted hatching in assisted reproduction | 20.0 | 0 | 1 |
| Zona hardening, zona drilling and assisted hatching: new achievements in assisted reproduction | 20.0 | 0 | 1 |
| Number of spermatozoa in the crypts of the sperm reservoir at about 24 h after a low-dose intrauterine and deep intrauterine insemination in sows. | 20.0 | 0 | 1 |
| The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study | 20.0 | 0 | 1 |
| Multiple failed intubation attempts are associated with decreased success rates on the first rescue intubation in the emergency department: a retrospective analysis of multicentre observational data | 20.0 | 0 | 1 |
| Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review | 20.0 | 0 | 1 |
| Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database | 20.0 | 0 | 1 |
| Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan | 20.0 | 0 | 1 |
| Low health literacy associated with higher medication costs in patients with type 2 diabetes mellitus: Evidence from matched survey and health insurance data. | 20.0 | 0 | 1 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 20.0 | 0 | 1 |
| Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. | 20.0 | 0 | 1 |
| Economic Evaluation of Targeted Antifungal Treatment Sequencing Strategies For Invasive Aspergillosis Based on Real World Data: The Case of Dutch Clinical Practice | 20.0 | 0 | 1 |
| High tuberculosis notification and treatment success rates through community participation in central Sulawesi, Republic of Indonesia. | 20.0 | 0 | 1 |
| Decision-making about fertility preservation—qualitative data on young cancer patients’ attitudes and needs | 20.0 | 0 | 1 |
| West Nile virus infections projected from blood donor screening data, United States, 2003 | 20.0 | 0 | 1 |
| Population patch clamp improves data consistency and success rates in the measurement of ionic currents | 20.0 | 0 | 1 |
| GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology | 20.0 | 0 | 1 |
| Objective data on DNA success rates can aid the selection process of crime samples for analysis by rapid mobile DNA technologies | 20.0 | 0 | 1 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 20.0 | 0 | 1 |
| Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy: Real-Life Practice Data Using CPRD. | 20.0 | 0 | 1 |
| Tissue perfusion essential for spermatogenesis and outcome of testicular sperm extraction (TESE) for assisted reproduction | 20.0 | 0 | 1 |
| Update on the comparison of assisted reproduction outcomes between Europe and the USA: the 2002 data | 20.0 | 0 | 1 |
| The German Middleway as Precursor for Single Embryo Transfer. A Retrospective Data-analysis of the Düsseldorf University Hospital's Interdisciplinary Fertility Centre - UniKiD. | 20.0 | 0 | 1 |
| Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections | 20.0 | 0 | 1 |
| Medical devices; obstetrical and gynecological devices; classification of the assisted reproduction laser system. Final rule. | 20.0 | 0 | 1 |
| The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data | 20.0 | 0 | 1 |
| Effect of gonadotropin-releasing hormone antagonists on intrauterine insemination cycles in women with polycystic ovary syndrome: a meta-analysis | 20.0 | 0 | 1 |
| Assisted reproduction: data from France | 20.0 | 0 | 1 |
| Effect of fibroids on fertility in patients undergoing assisted reproduction. A structured literature review | 20.0 | 0 | 1 |
| Possible applications of a non-contact 1.48 microm wavelength diode laser in assisted reproduction technologies | 20.0 | 0 | 1 |
| Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016 | 20.0 | 0 | 1 |
| Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients | 20.0 | 0 | 1 |
| Relationship of follicle numbers and estradiol levels to multiple implantation in 3,608 intrauterine insemination cycles | 20.0 | 0 | 1 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 20.0 | 0 | 1 |
| Does low penetration of human skin by the normal mode ruby laser account for poor permanent depilatory success rates? | 20.0 | 0 | 1 |
| Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment | 20.0 | 0 | 1 |
| Rapid assays for detection of anti-islet autoantibodies: implications for organ donor screening | 20.0 | 0 | 1 |
| Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows | 20.0 | 0 | 1 |
| A two- versus three-embryo transfer: the oocyte donation model | 20.0 | 0 | 1 |
| Intrauterine insemination: a systematic review on determinants of success | 20.0 | 0 | 1 |
| Birth of piglets after deep intrauterine insemination with flow cytometrically sorted boar spermatozoa | 20.0 | 0 | 1 |
| The effect of laparoscopic ablation or danocrine on pregnancy rates in patients with stage I or II endometriosis undergoing donor insemination | 20.0 | 0 | 1 |
| Depot versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: a Cochrane Review | 20.0 | 0 | 1 |
| Laser in assisted reproduction and genetics | 20.0 | 0 | 1 |
| One versus two inseminations per cycle in intrauterine insemination with sperm from patients' husbands: a systematic review of the literature | 20.0 | 0 | 1 |
| Proteomics in reproductive medicine: the technology for separation and identification of proteins | 20.0 | 0 | 1 |
| A randomized double-blind controlled study of the efficacy of laser-assisted hatching on implantation and pregnancy rates of frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Microscopical advances in assisted reproduction. | 20.0 | 0 | 1 |
| Formocresol and ferric sulfate have similar success rates in primary molar pulpotomy. In carious primary molars does a pulpotomy performed with ferric sulphate, compared with formocresol, result in greater clinical/radiographic success? | 20.0 | 0 | 1 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 20.0 | 0 | 1 |
| Improving success rates for lead generation using affinity binding technologies | 20.0 | 0 | 1 |
| Present state of reproductive medicine in Japan - ethical issues with a focus on those seen in court cases | 20.0 | 0 | 1 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 20.0 | 0 | 1 |
| Applications of microarray in reproductive medicine. | 20.0 | 0 | 1 |
| Pregnancy outcomes after assisted reproductive technology | 20.0 | 0 | 1 |
| A list and analysis of reproductive medicine periodicals indexed in MEDLINE in 2006 | 20.0 | 0 | 1 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 20.0 | 0 | 1 |
| Effect of passive uterine straightening during embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer | 20.0 | 0 | 1 |
| Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage. | 20.0 | 0 | 1 |
| Effect of laser zona pellucida opening on clinical outcome of assisted reproduction technology in patients with advanced female age, recurrent implantation failure, or frozen-thawed embryos | 20.0 | 0 | 1 |
| Emotional support, education and self-rated health in 22 European countries | 20.0 | 0 | 1 |
| Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Impact of stone location on success rates of endoscopic lithotripsy for nephrolithiasis | 20.0 | 0 | 1 |
| Effect of the size of zona pellucida opening by laser assisted hatching on clinical outcome of frozen cleaved embryos that were cultured to blastocyst after thawing in women with multiple implantation failures of embryo transfer: a retrospective stu | 20.0 | 0 | 1 |
| Impact of assisted hatching on fresh and frozen-thawed embryo transfer cycles: a prospective, randomized study | 20.0 | 0 | 1 |
| Pretreatments before the induction of ovulation in assisted reproduction technologies: evidence-based medicine in 2007. | 20.0 | 0 | 1 |
| The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. | 20.0 | 0 | 1 |
| Flow cytometric phenotyping of platelet HPA-1a antigen: donor screening for a case of neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies. | 20.0 | 0 | 1 |
| Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. | 20.0 | 0 | 1 |
| Statistical and methodological issues in the analysis of complex sample survey data: practical guidance for trauma researchers | 20.0 | 0 | 1 |
| Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents | 20.0 | 0 | 1 |
| GnRH-agonists in fertility preservation | 20.0 | 0 | 1 |
| Indications and options for endometrial ablation | 20.0 | 0 | 1 |
| Laparoscopic intrauterine insemination in Barbary sheep (Ammotragus lervia). | 20.0 | 0 | 1 |
| Alkylation of sperm DNA is associated with male factor infertility and a reduction in the proportion of oocytes fertilised during assisted reproduction. | 20.0 | 0 | 1 |
| Spontaneous ovulatory cycle donor insemination programme: prognostic indicators of a successful pregnancy | 20.0 | 0 | 1 |
| Controversies in clinical embryology: embryo selection towards single embryo transfer - 16 July 2008, University of Manchester | 20.0 | 0 | 1 |
| Effect of stem cell activation, culture media of manipulated embryos, and site of embryo transfer in the production of F0 embryonic stem cell mice. | 20.0 | 0 | 1 |
| Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine | 20.0 | 0 | 1 |
| Multifetal gestations with assisted reproductive technique before the single-embryo transfer legislation: obstetric, neonatal outcomes and congenital anomalies | 20.0 | 0 | 1 |
| Fatal alloimmune thrombocytopenia due to anti-HLA alloimmunization in a twin pregnancy: A very infrequent complication of assisted reproduction | 20.0 | 0 | 1 |
| Letter: Sperm bank for sterilized males | 20.0 | 0 | 1 |
| Creation and Use of a Scrotal Sperm Bank in Aplasia of the Vas Deferens | 20.0 | 0 | 1 |
| The birth of a feminist sperm bank: new social agendas for AID | 20.0 | 0 | 1 |
| The Nobel sperm bank: an affront to humanism | 20.0 | 0 | 1 |
| The Nobel sperm bank revisited | 20.0 | 0 | 1 |
| "Sperm bank" integration - accident or fiction? | 20.0 | 0 | 1 |
| Revealing the identity of sperm bank donors | 20.0 | 0 | 1 |
| PRELIMINARY EXPERIENCE WITH A HUMAN SPERM BANK. | 20.0 | 0 | 1 |
| The establishment and application of network human sperm bank management information system | 20.0 | 0 | 1 |
| Effect of long-term storage on deoxyribonucleic acid damage and motility of sperm bank donor specimens | 20.0 | 0 | 1 |
| Donor screening for hepatitis B virus infection in a cell and tissue bank | 20.0 | 0 | 1 |
| Long-term cryostorage of sperm in a human sperm bank does not damage progressive motility concentration | 20.0 | 0 | 1 |
| Freezability and Semen Parameters in Candidates of Sperm Bank Donors: 1992–2010 | 20.0 | 0 | 1 |
| Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types | 20.0 | 0 | 1 |
| Analysis of the pregnancy outcomes of 13 723 tubes of sperm specimens from the sperm bank | 20.0 | 0 | 1 |
| Advances in microsurgery and assisted reproduction for management of male infertility | 20.0 | 0 | 1 |
| Trends and usage in a London National Health Service Sperm Bank for cancer patients | 20.0 | 0 | 1 |
| Decline in sperm count and motility in young adult men from 2003 to 2013: observations from a U.S. sperm bank | 20.0 | 0 | 1 |
| Multivariate model for predicting semen cryopreservation outcomes in a human sperm bank | 20.0 | 0 | 1 |
| Decline of semen quality among Chinese sperm bank donors within 7 years (2008-2014) | 20.0 | 0 | 1 |
| The Munich cryopreserved sperm bank--intermediate 1974-1986 evaluation | 20.0 | 0 | 1 |
| Survival of spermatozoa in a human sperm bank. Effects of long-term storage in liquid nitrogen | 20.0 | 0 | 1 |
| Organization of a human sperm bank. Some problems | 20.0 | 0 | 1 |
| A sperm bank | 20.0 | 0 | 1 |
| Clinical Aspects of Sperm Bank | 20.0 | 0 | 1 |
| Donor insemination employing deep-frozen semen from a central bank | 20.0 | 0 | 1 |
| Medico-genetic justifications for artificial heterologous insemination and the use of a sperm bank | 20.0 | 0 | 1 |
| Sperm Bank Potentials in the Management of Malignancy | 20.0 | 0 | 1 |
| Mutation analysis for cystic fibrosis to determine carrier status in 167 sperm donors from the Nebraska Genetic Semen Bank | 20.0 | 0 | 1 |
| Reasons for rejecting potential donors from a sperm bank program | 20.0 | 0 | 1 |
| Low versus atmospheric oxygen tension for embryo culture in assisted reproduction: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Blood group genotyping: from patient to high-throughput donor screening | 20.0 | 0 | 1 |
| Incorporating natural variation into IVF clinic league tables: The Expected Rank | 20.0 | 0 | 1 |
| Significance of reproductive medicine in regard to judicial and ethical concerns in Germany | 20.0 | 0 | 1 |
| Embryo recovery rate and recipients' pregnancy rate after nonsurgical embryo transfer in donkeys | 20.0 | 0 | 1 |
| Effect of laser zona thinning on vitrified-warmed embryo transfer at the cleavage stage: a prospective, randomized study | 20.0 | 0 | 1 |
| Embryo transfer in rabbits | 20.0 | 0 | 1 |
| Reproductive endocrinology: quo vadis? Scientific, social, ethical and economic challenges. | 20.0 | 0 | 1 |
| Does assisted reproduction make an impact on the identity and self-image of infertile couples? | 20.0 | 0 | 1 |
| Does assisted reproduction make an impact on the identity and self-esteem of infertile women during the transition to parenthood? | 20.0 | 0 | 1 |
| Assisted reproduction for the treatment of azoospermia | 20.0 | 0 | 1 |
| Ovarian markers of implantation potential in assisted reproduction | 20.0 | 0 | 1 |
| The application of co-culture in assisted reproduction: 10 years of experience with human embryos | 20.0 | 0 | 1 |
| Hyperactivated motility of human spermatozoa: a review of physiological function and application in assisted reproduction | 20.0 | 0 | 1 |
| Preparation of endometrium for egg donation | 20.0 | 0 | 1 |
| More than "bandaids": emotional support and education during the downsizing process | 20.0 | 0 | 1 |
| Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome | 20.0 | 0 | 1 |
| Primate Follicular Development and Oocyte Maturation In Vitro | 20.0 | 0 | 1 |
| Dairy intake and semen quality among men attending a fertility clinic | 20.0 | 0 | 1 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 20.0 | 0 | 1 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 20.0 | 0 | 1 |
| Abuse in childhood and risk of uterine leiomyoma: the role of emotional support in biologic resilience | 20.0 | 0 | 1 |
| Pre-hCG 3D and 3D power Doppler assessment of the follicle for improving pregnancy rates in intrauterine insemination cycles | 20.0 | 0 | 1 |
| Package pricing roils cardiac, orthopedic services. | 20.0 | 0 | 1 |
| Institutional review boards (IRBs) and reproductive medicine: guidelines for compliance | 20.0 | 0 | 1 |
| The status of assisted reproductive technology in Korea in 2012 | 20.0 | 0 | 1 |
| Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities | 20.0 | 0 | 1 |
| 'What Does Donor Mean to a Four-Year-Old?': Initial Insights into Young Children's Perspectives in Solo Mother Families | 20.0 | 0 | 1 |
| The State of Reproductive Medicine in Germany | 20.0 | 0 | 1 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 20.0 | 0 | 1 |
| Assessment of endometrial and ovarian characteristics using three dimensional power Doppler ultrasound to predict response in frozen embryo transfer cycles | 20.0 | 0 | 1 |
| Elective single embryo transfer following in vitro fertilization | 20.0 | 0 | 1 |
| Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic | 20.0 | 0 | 1 |
| Retrospective clinical analysis of two artificial shrinkage methods applied prior to blastocyst vitrification on the outcome of frozen embryo transfer | 20.0 | 0 | 1 |
| Serum progesterone concentration on day of embryo transfer in donor oocyte cycles | 20.0 | 0 | 1 |
| Efficacy of sperm motility after processing and incubation to predict pregnancy after intrauterine insemination in normospermic individuals | 20.0 | 0 | 1 |
| Childbirth and fertility preservation in childhood and adolescent cancer patients: a second national survey of Japanese pediatric endocrinologists | 20.0 | 0 | 1 |
| Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT | 20.0 | 0 | 1 |
| The Internet, intranets and reproductive medicine | 20.0 | 0 | 1 |
| What factors are important for successful embryo transfer after in-vitro fertilization? | 20.0 | 0 | 1 |
| The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial | 20.0 | 0 | 1 |
| Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical tri | 20.0 | 0 | 1 |
| Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management | 20.0 | 0 | 1 |
| Personalised predictions of endovascular aneurysm repair success rates: validating the ERA model with UK Vascular Institute data. | 20.0 | 0 | 1 |
| Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options | 20.0 | 0 | 1 |
| Attitudes of Infertile Couples, Fertility Clinic Staff and Researchers toward Personhood of The Human Embryo in Iran | 20.0 | 0 | 1 |
| Comments regarding 'Personalised predictions of endovascular aneurysm repair success rates: validating the ERA model with UK Vascular Institute data'. | 20.0 | 0 | 1 |